Deferred Tax Assets, Valuation Allowance of Odyssey Health, Inc. from 31 Jul 2014 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Odyssey Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Jul 2014 to 31 Jul 2025.
  • Odyssey Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Jul 2025 was $12,453,700, a 2.2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Odyssey Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $12,453,700 +$271,100 +2.2% 31 Jul 2025 10-K 29 Oct 2025 2025 FY
Q2 2024 $12,182,600 +$9,222,200 +312% 31 Jul 2024 10-K 29 Oct 2025 2025 FY
Q2 2023 $2,960,400 +$485,300 +20% 31 Jul 2023 10-K 13 Nov 2024 2024 FY
Q2 2022 $2,475,100 +$885,400 +56% 31 Jul 2022 10-K 30 Oct 2023 2023 FY
Q2 2021 $1,589,700 +$1,182,300 +290% 31 Jul 2021 10-K 31 Oct 2022 2022 FY
Q2 2020 $407,400 +$161,200 +65% 31 Jul 2020 10-K 29 Oct 2021 2021 FY
Q2 2019 $246,200 31 Jul 2019 10-K 16 Nov 2020 2021 FY
Q2 2016 $137,171 +$30,141 +28% 31 Jul 2016 10-K 02 Nov 2016 2016 FY
Q1 2016 $133,027 30 Apr 2016 10-Q 16 Jun 2016 2016 Q3
Q4 2015 $130,162 +$45,965 +55% 31 Jan 2016 10-Q 15 Mar 2016 2016 Q2
Q3 2015 $115,778 +$49,774 +75% 31 Oct 2015 10-Q 22 Dec 2015 2016 Q1
Q2 2015 $107,030 +$56,244 +111% 31 Jul 2015 10-K 02 Nov 2016 2016 FY
Q4 2014 $84,197 31 Jan 2015 10-Q 15 Mar 2016 2016 Q2
Q3 2014 $66,004 31 Oct 2014 10-Q 22 Dec 2015 2016 Q1
Q2 2014 $50,786 31 Jul 2014 10-K 01 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.